EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan

Ryosuke Hirai iD, Yoichi Yamamoto iD, Takeshi Yasuda iD, Takumi Yanagita iD, Taro Iwatsubo iD, Yasuhiro Tani iD, Shunsuke Yoshii iD, Yuhei Sakata iD, Hiroyoshi Iwagami iD, Takahito Nozaka iD, Takeshi Uozumi iD, Yuichi Masui iD und 17 weitere

Digestive Endoscopy · 2026

DOI: 10.1111/den.70206 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive Endoscopy, 2026. Verfasst von Ryosuke Hirai und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayam…. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Platelet Aggregation Inhibitors, Postoperative Hemorrhage, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Postendoscopic submucosal dissection (ESD) bleeding remains a critical concern in patients receiving antithrombotic therapy, yet the risk after esophageal ESD is poorly characterized. This multicenter retrospective study evaluated the incidence of post‐ESD bleeding and thromboembolism in patients undergoing esophageal ESD while receiving antiplatelet therapy.

Methods

We analyzed 570 patients with esophageal squamous cell carcinoma treated with ESD while on antiplatelet therapy between 2017 and 2022 at 21 institutions in Japan. Patients were categorized into guideline‐based discontinuation or continuation, excluding guideline‐deviating discontinuation. The primary endpoint was the rate of post‐ESD bleeding among thienopyridine users (monotherapy or dual antiplatelet therapy; DAPT) managed with guideline‐based discontinuation. Secondary endpoints included bleeding rates according to antiplatelet regimen and thromboembolism incidence.

Results

A total of 154, 41, and 375 patients received thienopyridine monotherapy, DAPT, and aspirin monotherapy, respectively. Antiplatelet therapy was continued perioperatively in 32.5%, 31.7%, and 73.1% of these groups. Post‐ESD bleeding rates were 2.3% (3/132) and 3.2% (2/63) for guideline‐based discontinuation and continuation of thienopyridine users, respectively. Bleeding rates for discontinuation vs. continuation were 0% (0/101) vs. 0.7% (2/274) for aspirin monotherapy, 1.9% (2/104) vs. 4.0% (2/50) for thienopyridine monotherapy, and 3.6% (1/28) vs. 0% (0/13) for DAPT. Thromboembolism occurred in two patients, both receiving aspirin monotherapy.

Conclusions

A substantial number of patients underwent esophageal ESD while continuing antiplatelet therapy. These descriptive findings suggest a need for further evaluation of continued therapy in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionPlatelet Aggregation InhibitorsPostoperative HemorrhageEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansRetrospective StudiesMaleJapanFemaleAgedMiddle AgedIncidenceThromboembolismAged, 80 and over

Stichwörter der Autor:innen

antiplatelet therapyesophageal endoscopic submucosal dissectionpostoperative bleedingthienopyridine derivatives

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan.
  • Division of Endoscopy, Shizuoka Cancer Center, Suntougun, Shizuoka, Japan.
  • Department of Gastroenterology, Akashi City Hospital, Akashi, Hyogo, Japan.
  • Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
  • Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan.

ORCID-Profile: Ryosuke Hirai, Yoichi Yamamoto, Takeshi Yasuda, Takumi Yanagita, Taro Iwatsubo, Yasuhiro Tani, Shunsuke Yoshii, Yuhei Sakata, Hiroyoshi Iwagami, Takahito Nozaka, Takeshi Uozumi, Yuichi Masui, Jun Konishi, Kazuo Shiotsuki, Koyo Kido, Yuki Kano, Ken Ohata, Noriko Matsuura, Akira Dobashi, Yusuke Yoda, Saeko Kushida, Yoshinobu Yamamoto, Yuji Urabe, Toshiyuki Yoshio, Seiichiro Abe, Tomohiro Kadota, Kohei Takizawa, Tomonori Yano, Hiroyuki Ono

Zitieren

APA

Hirai, R., Yamamoto, Y., Yasuda, T., Yanagita, T., Iwatsubo, T., Tani, Y., Yoshii, S., Sakata, Y., Iwagami, H., Nozaka, T., Uozumi, T., Masui, Y., Konishi, J., Shiotsuki, K., Kido, K., Kano, Y., Ohata, K., Matsuura, N., Dobashi, A., …, & Ono, H. (2026). Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan. Digestive Endoscopy. https://doi.org/10.1111/den.70206

Vancouver

Hirai R, Yamamoto Y, Yasuda T, Yanagita T, Iwatsubo T, Tani Y, et al. Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan. Digestive Endoscopy. 2026. doi:10.1111/den.70206

BibTeX
@article{Hirai2026,
  author = {Hirai, Ryosuke and Yamamoto, Yoichi and Yasuda, Takeshi and Yanagita, Takumi and Iwatsubo, Taro and Tani, Yasuhiro and Yoshii, Shunsuke and Sakata, Yuhei and Iwagami, Hiroyoshi and Nozaka, Takahito and Uozumi, Takeshi and Masui, Yuichi and Konishi, Jun and Shiotsuki, Kazuo and Kido, Koyo and Kano, Yuki and Ohata, Ken and Matsuura, Noriko and Dobashi, Akira and Yoda, Yusuke and Kushida, Saeko and Yamamoto, Yoshinobu and Urabe, Yuji and Yoshio, Toshiyuki and Abe, Seiichiro and Kadota, Tomohiro and Takizawa, Kohei and Yano, Tomonori and Ono, Hiroyuki},
  title = {Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan},
  journal = {Digestive Endoscopy},
  year = {2026},
  doi = {10.1111/den.70206}
}
Kostenlos starten →